134 related articles for article (PubMed ID: 10615393)
1. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator.
Schulze K; Witzenbichler B; Christmann C; Schultheiss HP
Cardiovasc Res; 1999 Oct; 44(1):91-100. PubMed ID: 10615393
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.
Schulze K; Becker BF; Schultheiss HP
Circ Res; 1989 Feb; 64(2):179-92. PubMed ID: 2536302
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.
Schulze K; Becker BF; Schauer R; Schultheiss HP
Circulation; 1990 Mar; 81(3):959-69. PubMed ID: 2155073
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure?
Schultheiss HP; Schulze K; Schauer R; Witzenbichler B; Strauer BE
Circ Res; 1995 Jan; 76(1):64-72. PubMed ID: 8001279
[TBL] [Abstract][Full Text] [Related]
5. Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms.
Schultheiss HP
Circulation; 1993 May; 87(5 Suppl):IV43-8. PubMed ID: 8485833
[TBL] [Abstract][Full Text] [Related]
6. The role of the ADP/ATP carrier in the pathogenesis of viral heart disease.
Schulze K; Schultheiss HP
Eur Heart J; 1995 Dec; 16 Suppl O():64-7. PubMed ID: 8682105
[TBL] [Abstract][Full Text] [Related]
7. The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy--clinical and experimental data.
Schultheiss HP
Springer Semin Immunopathol; 1989; 11(1):15-30. PubMed ID: 2546261
[No Abstract] [Full Text] [Related]
8. Impairment of myocardial calcium homeostasis by antibodies against the adenine nucleotide translocator.
Schulze K; Heineman FW; Schultheiss HP; Balaban RS
Cell Calcium; 1999 May; 25(5):361-70. PubMed ID: 10463100
[TBL] [Abstract][Full Text] [Related]
9. Significance of the adenine nucleotide translocator in the pathogenesis of viral heart disease.
Schultheiss HP; Schulze K; Dörner A
Mol Cell Biochem; 1996; 163-164():319-27. PubMed ID: 8974071
[TBL] [Abstract][Full Text] [Related]
10. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
Neumann DA; Rose NR; Ansari AA; Herskowitz A
J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
[TBL] [Abstract][Full Text] [Related]
11. [Effect of IL-17A on levels of antiheart autoantibodies in mice with viral myocarditis].
Lai W; Wu W; Pan X; Kong Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):601-3, 607. PubMed ID: 24909282
[TBL] [Abstract][Full Text] [Related]
12. Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease.
Schwimmbeck PL; Schwimmbeck NK; Schultheiss HP; Strauer BE
Clin Immunol Immunopathol; 1993 Aug; 68(2):135-40. PubMed ID: 7689426
[No Abstract] [Full Text] [Related]
13. Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function.
Dörner A; Schulze K; Rauch U; Schultheiss HP
Mol Cell Biochem; 1997 Sep; 174(1-2):261-9. PubMed ID: 9309698
[TBL] [Abstract][Full Text] [Related]
14. Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis--incidence and relation to cardiac function and morphology.
Takemoto M; Kusachi S; Urabe N; Inoue K; Tsuji T
Jpn Circ J; 1993 Dec; 57(12):1150-8. PubMed ID: 8283607
[TBL] [Abstract][Full Text] [Related]
15. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease.
Walther T; Tschöpe C; Sterner-Kock A; Westermann D; Heringer-Walther S; Riad A; Nikolic A; Wang Y; Ebermann L; Siems WE; Bader M; Shakibaei M; Schultheiss HP; Dörner A
Circulation; 2007 Jan; 115(3):333-44. PubMed ID: 17210842
[TBL] [Abstract][Full Text] [Related]
16. Study of autoantibodies against the adenine nucleotide translocator in idiopathic dilated cardiomyopathy.
Zhang WG; Ma AQ; Wei J; Feng QM; Liu ZQ
Blood Press Suppl; 1996; 3():45-8. PubMed ID: 8973769
[TBL] [Abstract][Full Text] [Related]
17. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy.
Schwimmbeck PL; Bland NK; Schultheiss HP; Strauer BE
Eur Heart J; 1991 Aug; 12 Suppl D():76-80. PubMed ID: 1717275
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy.
Schultheiss HP
Basic Res Cardiol; 1992; 87 Suppl 1():311-20. PubMed ID: 1497575
[TBL] [Abstract][Full Text] [Related]
19. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy.
Schultheiss HP; Bolte HD
J Mol Cell Cardiol; 1985 Jun; 17(6):603-17. PubMed ID: 2991541
[TBL] [Abstract][Full Text] [Related]
20. The rate of ATP export in the extramitochondrial phase via the adenine nucleotide translocator changes in aging in mitochondria isolated from heart left ventricle of either normotensive or spontaneously hypertensive rats.
Atlante A; Seccia TM; Marra E; Passarella S
Mech Ageing Dev; 2011 Oct; 132(10):488-95. PubMed ID: 21855562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
